Edoxaban, warfarin equally effective for reducing adverse events in AFib patients with liver disease - Cardiovascular Business

Edoxaban, warfarin equally effective for reducing adverse events in AFib patients with liver disease  Cardiovascular Business

Edoxaban and warfarin are equally effective in reducing the risk of stroke, systemic embolic events and major bleeding in patients with atrial fibrillation and a ...